There is a good chance that the first corona vaccines – from BioNtech-Pfizer and Moderna – will be licensed by Europe before the end of the year. This was announced by Commission President Ursula von der Leyen. Good news in the fight against the virus. Not so good news: the strategy for marketing those vaccines is nowhere to be found. Jan De Maeseneer (UGent), professor emeritus of family medicine and international authority in public health, answers the most important questions. “We have to gear up now.”
–
Who Should Get a Vaccine First?
“I follow the advice of the Superior Health Council: first the approximately 400,000 health workers, then the over-65s and the chronically ill between 45 and 65 years,” says De …
– .
